Natixis Advisors, L.P. Tandem Diabetes Care Inc Transaction History
Natixis Advisors, L.P.
- $46 Billion
- Q2 2024
A detailed history of Natixis Advisors, L.P. transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 53,244 shares of TNDM stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,244
Previous 50,210
6.04%
Holding current value
$1.74 Million
Previous $1.78 Million
20.64%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TNDM
# of Institutions
351Shares Held
73MCall Options Held
3.12MPut Options Held
343K-
Black Rock Inc. New York, NY11.1MShares$364 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.38MShares$241 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA3.67MShares$120 Million0.02% of portfolio
-
State Street Corp Boston, MA2.57MShares$84.2 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.5MShares$82 Million1.33% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $2.1B
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...